Home > Resources > Whitepapers > Biotech reinvented

Biotech reinvented

March 20, 2019

The biotechnology industry (Biotech) is now about 30 years old – a long enough time in which to evaluate how it’s done. Unfortunately, despite some notable successes, it hasn’t completely fulfilled its promise. The business model on which Biotech has historically relied is also breaking down, as the research base moves east and raising funds gets harder. And the distinctions between Biotech and the pharmaceutical industry (Pharma) are disappearing, with the convergence of the two sectors. But Biotech can’t turn to Pharma for guidance because Pharma’s business model has other flaws – as we explained in “Pharma 2020: Challenging business models”, the White Paper we published in April 2009.1 So what should Biotech do? We believe it should capitalise on the opportunities emerging in the healthcare arena – and reinvent itself by adopting a more collaborative approach.

Spotlight

BioMed Valley Discoveries, Inc

BioMed Valley Discoveries, Inc., is a clinical stage biotechnology company with a mission to address unmet patient needs across a wide spectrum of diseases. BioMed Valley Discoveries leverage several hundred experts at leading academic and clinical institutions to move projects forward in the early stages of clinical development. Our partners have a proven track record of scientific rigor and experience in efficient study execution.

OTHER WHITEPAPERS

The US Bioeconomy

whitePaper | April 14, 2022

In the nearly 50 years since the first genetic engineering experiments, the United States has become the world’s biotechnology powerhouse,

DIGITAL BIOTECH IS MISSION-CRITICAL TO MODERNA

whitePaper | May 20, 2022

We are living in a unique time in which the world is changing faster than ever. This largely is due to an influx and infusion of digital technologies that are reinventing and reimagining businesses across nearly every sector, and dramatically shifting societal and economic interactions. While the life science industry has, to some extent, adopted various digital technologies, it has not had a significant digital transformation in how it does business.

How advanced purification technologies are speeding the hunt for new protections against disease

whitePaper | November 24, 2022

Smallpox was the first infectious disease for which an effective vaccine was developed. In the late 1700s, British doctor Edward Jenner devised a method to inoculate people with cowpox pus to give them immunity against smallpox, a much more deadly disease.